EGAS00001002964-sc-2020-09-29T08:57:44Z - samples

ABSTRACT: Leukaemia and related blood cancers occur due to genetic changes that typically accumulate over many years. This study will employ targeted next-generation sequencing to retrace the preclinical evolution of several types of haematological malignancy. Investigating the progression of the earliest pre-malignant ancestral clones promises to offer valuable insights into early leukaemia evolution and therapeutic vulnerabilities of leukaemia stem cells.

PROVIDER: EGAD00001006424 | EGA |

REPOSITORIES: EGA